Monday 22 September 2008
A new technology that enables scientists to identify proteins by making a map of the energy flow inside the protein was revealed on 22 September 2008 in Proceedings of the National Academy of Sciences (PNAS) journal. The research explores how an imaging technique known as coherent two-dimensional infrared spectroscopy, 2DIR, has been used to successfully identify proteins in laboratory tests.
The scientists behind the new technology hope to develop a tool which can be used to analyse human cells and find out which proteins are present and in what quantities. Being able to sensitively analyse the protein make-up of cells is important because proteins are involved in every process in human cells, including the development of cancer.
This research is performed by The Single Cell Proteomics group at Imperial College London, which was established in 2006 with £5 million funding from the EPSRC and BBSRC and will run for five and a half years. Professor Keith Willison, Professor of Molecular Cell Biology at The Institute of Cancer Research, is a co-holder of the £5M grant and a collaborator on this research.
The 2DIR technique uses an ultra short pulse of infra-red laser light to cause a vibration in one part of the protein molecule. The researchers then track the movement of energy from this vibration as it moves through the protein, building up an energy flow map of the protein which enables them to identify what kind of protein it is.
Professor David Klug from the Single Cell Proteomics project at Imperial College London, one of the authors of the new paper, explains the significance of their study: “We have proved the principle that it is possible to use this type of spectroscopy to identify proteins and we are now looking to use this knowledge to develop a new tool that can be used to further a broad range of research including drug discovery, diagnostics, biomarker discovery and basic biology.
"This is the first time in over 20 years that a new method for identifying proteins has been discovered, and we're very excited about the possibilities that it will bring to our field."
Professor Keith Willison, Professor of Molecular Cell Biology at The Institute of Cancer Research and also an author on the paper, adds: "the development of new single cell, single molecule approaches is vital in the hunt for rare cancer cells."
The technologies under development in the Single Cell Proteomics Project are focussed on improving the sensitivities of proteomic tools to allow single cells to be analysed. Currently, scientists identify and count proteins either by using antibodies or mass spectrometry. The new third potential method, 2DIR, has advantages over the existing methods because it could be more sensitive and provide additional information on how protein activity and function is modulated within cells. "Counting the number of proteins is important, but not enough to understand the biology at work," says Professor Klug.
Potential applications of these methods include the possibility to analyse single cancer cells found circulating in the bloodstream of patients and in the discovery of new biomarkers that might ultimately be used in screening and diagnosis.
The study of proteins, known as proteomics, is the next step for scientists following the identification of all the genes in human DNA in the human genome project. All human cells contain the same 20,000 genes but in different cells different genes are 'switched on' to produce different proteins, and it is the differences between proteins which distinguishes one type of cell from another, and a healthy cell from a diseased cell.
For more information on the Single Cell Proteomics project go to www.singlecellproteomics.ac.uk.
- ends -
For more information please contact:
Mike Foster
The Institute of Cancer Research
0207 153 5106 / 07721 747900
[email protected]
Notes to editors:
'Protein identification and quantification by two-dimensional infrared spectroscopy: implications for an all optical proteomic platform’, Proceedings of the National Academy of Sciences, advanced online publication, Monday 22 September 2008.
Frederic Fournier (1), Elizabeth M. Gardner (1), Darek A. Kedra (2), Paul M. Donaldson (1), Rui Guo (1), Sarah A. Butcher (2),Ian R. Gould (1), Keith R. Willison (3), and David R. Klug (1).
(1) Department of Chemistry and Chemical Biology Centre, Imperial College London, Exhibition Road, London SW7 2AZ, United Kingdom
(2) Bioinformatics Support Service, Division of Molecular Biosciences, Imperial College London, Exhibition Road, London SW7 2AZ, United Kingdom
(3) The Institute of Cancer Research, Chester Beatty Laboratories, Cancer Research UK, Centre of Cellular and Molecular Biology, London SW3 6JB, United Kingdom
'Protein identification and quantification by two-dimensional infrared spectroscopy: implications for an all optical proteomic platform', Proceedings of the National Academy of Sciences, advanced online publication, Monday 22 September 2008.
Frederic Fournier (1), Elizabeth M. Gardner (1), Darek A. Kedra (2), Paul M. Donaldson (1), Rui Guo (1), Sarah A. Butcher (2),Ian R. Gould (1), Keith R. Willison (3), and David R. Klug (1).
(1) Department of Chemistry and Chemical Biology Centre, Imperial College London, Exhibition Road, London SW7 2AZ, United Kingdom
(2) Bioinformatics Support Service, Division of Molecular Biosciences, Imperial College London, Exhibition Road, London SW7 2AZ, United Kingdom
(3) The Institute of Cancer Research, Chester Beatty Laboratories, Cancer Research UK, Centre of Cellular and Molecular Biology, London SW3 6JB, United Kingdom
- About Imperial College London
Imperial College London - rated the world’s fifth best university in the 2007 Times Higher Education Supplement University Rankings - is a science-based institution with a reputation for excellence in teaching and research that attracts 12,000 students and 6,000 staff of the highest international quality.
Innovative research at the College explores the interface between science, medicine, engineering and business, delivering practical solutions that improve quality of life and the environment - underpinned by a dynamic enterprise culture.
Website: www.imperial.ac.uk - About the Chemical Biology Centre
The Chemical Biology Centre brings together life scientists and physical scientists from three of London's most prestigious Research Centres - Imperial College London, The Institute of Cancer Research and the London Research Institute of Cancer Research UK. The Centre's interests lie in understanding the molecular details of biological activity at and near the membrane and in the education of young scientists in multidisciplinary research in the area of protein-protein & protein-lipid interaction.
Website: www.chemicalbiology.ac.uk - About The Institute of Cancer Research
The Institute of Cancer Research is Europe’s leading cancer research centre with expert scientists working on cutting edge research. It was founded in 1909 to carry out research into the causes of cancer and to develop new strategies for its prevention, diagnosis, treatment and care. For more information visit www.icr.ac.uk. The Institute is a charity that relies on voluntary income. The Institute is one of the world’s most cost-effective major cancer research organisations with over 95p in every £ of total income directly supporting research Website: www.icr.ac.uk